Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: A phase I and II study
Authors:
- John C. WainJWJohn C. Wain
- Thomas J. LynchTLThomas J. Lynch
- Noah C. ChoiNCNoah C. Choi
- Michael L. GrossbardMGMichael L. Grossbard
- Robert W. CareyRCRobert W. Carey
- Ashby C. MoncureAMAshby C. Moncure
- Hermes C. GrilloHGHermes C. Grillo
- Douglas J. MathisenDMDouglas J. Mathisen
Open Access
- 30 November 1997
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 114 (5) , 811-816
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A Comparison of Multimodal Therapy and Surgery for Esophageal AdenocarcinomaNew England Journal of Medicine, 1996
- Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junctionThe Annals of Thoracic Surgery, 1994
- Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the EsophagusJNCI: Journal of the National Cancer Institute, 1994
- Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report.Journal of Clinical Oncology, 1993
- Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the EsophagusNew England Journal of Medicine, 1992
- Taxol: A novel radiation sensitizerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992